Related references
Note: Only part of the references are listed.Synthesis and Biological Activity of 2,22-Dimethylene Analogues of 19-Norcalcitriol and Related Compounds
Izabela K. Sibilska-Kaminski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Vitamin D and Its Synthetic Analogs
Miguel A. Maestro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds
Izabela K. Sibilska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis and Biological Activity of 25-Hydroxy-2-methylene-vitamin D3 Analogues Monohydroxylated in the A-ring
Izabela K. Sibilska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Molecular Mechanisms of Vitamin D Action
Mark R. Haussler et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Synthesis and biological activity of 25-hydroxy-2-methylene-vitamin D3 compounds
Izabela Sibilska et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
A-ring analogs of 1,25-dihydroxyvitamin D3
Agnieszka Glebocka et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Vitamin D receptor ligands: the impact of crystal structures
Carsten Carlberg et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
A 20S Combined with a 22R Configuration Markedly Increases both in Vivo and in Vitro Biological Activity of 1α,25-Dihydroxy-22-methyl-2-methylene-19-norvitamin D3
Agnieszka Flores et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Vitamin D Analogue 2MD Increases Bone Turnover but Not BMD in Postmenopausal Women With Osteopenia: Results of a 1-Year Phase 2 Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Hector F. DeLuca et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
1-Desoxy analog of 2MD: Synthesis and biological activity of (20S)-25-hydroxy-2-methylene-19-norvitamin D3
Izabela Sibilska et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1α-hydroxyvitamin D3-26,23-lactones -: weak agonists
Grazia Chiellini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
New 2-alkylidene 1α,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity:: Synthesis and biological evaluation of 2-(3′-alkoxypropylidene) and 2-(3-hydroxypropylidene) derivatives
Agnieszka Glebocka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
2MD, a new anabolic agent for osteoporosis treatment
LA Plum et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Ligand recognition by vitamin D receptor: Total alanine scanning mutational analysis of the residues lining the ligand binding pocket of vitamin D receptor
Sachiko Yamada et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
NMR assignments of tryptophan residue in apo and holo LBD-rVDR
W Sicinska et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia
HZ Ke et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts
H Yamamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation
NK Shevde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
New highly calcemic 1 alpha,25-dihydroxy-19-norvitamin D-3 compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series
RR Sicinski et al.
STEROIDS (2002)
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
N Rochel et al.
MOLECULAR CELL (2000)
Share Paper
